Koers Jiangsu Jibeier Pharmaceutical Co., Ltd.
Aandelen
688566
CNE100004041
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
26,4 CNY | +5,05% | +16,87% | -15,90% |
Omzet 2023 * | 861 mln. 119 mln. 111 mln. | Omzet 2024 * | 1,08 mld. 149 mln. 139 mln. | Marktkapitalisatie | 4,99 mld. 690 mln. 643 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | 216 mln. 29,84 mln. 27,84 mln. | Nettowinst (verlies) 2024 * | 269 mln. 37,17 mln. 34,68 mln. | EV/omzet 2023 * | 5,8 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 4,64 x |
K/w-verhouding 2023 * |
23,2
x | K/w-verhouding 2024 * |
18,6
x | Werknemers | 1.016 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 24,56% |
1 dag | +5,05% | ||
1 week | +16,87% | ||
Lopende maand | +8,11% | ||
1 maand | +0,80% | ||
3 maanden | +0,57% | ||
6 maanden | +6,07% | ||
Lopend jaar | -15,90% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zhong yi Geng
CEO | Chief Executive Officer | 61 | 13-11-01 |
Suo Fu Zhao
DFI | Director of Finance/CFO | 57 | 08-05-17 |
Zheng Wang
CHM | Chairman | 47 | 13-11-01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guo Xiang Yang
BRD | Director/Board Member | 72 | 10-05-18 |
Zhu Yun Xie
BRD | Director/Board Member | 49 | 10-05-18 |
Zhong yi Geng
CEO | Chief Executive Officer | 61 | 13-11-01 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 26,4 | +5,05% | 3 044 990 |
24-04-24 | 25,13 | +1,29% | 2 132 363 |
23-04-24 | 24,81 | +7,26% | 2 400 746 |
22-04-24 | 23,13 | +4,57% | 1 493 093 |
19-04-24 | 22,12 | -4,16% | 1 586 846 |
slotkoers Shanghai S.E., 25 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,90% | 656 mln. | |
+4,16% | 70,78 mld. | |
+10,72% | 9,15 mld. | |
-17,03% | 4,84 mld. | |
+37,51% | 4,22 mld. | |
+3,92% | 3,92 mld. | |
+18,14% | 2,55 mld. | |
-24,13% | 2,26 mld. | |
-29,70% | 2,24 mld. | |
+9,09% | 1,92 mld. |